The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Macroglia-Microglia Interactions via TSPO Signaling Regulates Microglial Activation in the Mouse Retina
Open accessAbstract
Chronic retinal inflammation in the form of activated microglia and macrophages are implicated in the etiology of neurodegenerative diseases of the retina, including age-related macular degeneration, diabetic retinopathy, and glaucoma. However, molecular biomarkers and targeted therapies for immune cell activation in these disorders are currently lacking. To address this, we investigated the involvement and role of translocator protein (TSPO), a biomarker of microglial and astrocyte gliosis in brain degeneration, in the context of retinal inflammation. Here, we find that TSPO is acutely and specifically upregulated in retinal microglia in separate mouse models of retinal inflammation and injury. Concomitantly, its endogenous ligand, diazepam-binding inhibitor (DBI), is upregulated in the macroglia of the mouse retina such as astrocytes and Müller cells. In addition, we discover that TSPO-mediated signaling in microglia via DBI-derived ligands negatively regulates features of microglial activation, including reactive oxygen species production, TNF-α expression and secretion, and microglial proliferation. The inducibility and effects of DBI-TSPO signaling in the retina reveal a mechanism of coordinated macroglia-microglia interactions, the function of which is to limit the magnitude of inflammatory responses after their initiation, facilitating a return to baseline quiescence. Our results indicate that TSPO is a promising molecular marker for imaging inflammatory cell activation in the retina and highlight DBI-TSPO signaling as a potential target for immodulatory therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 1×
“Heterozygous CX3CR1 /GFP transgenic animals were created by breeding CX3CR1 GFP/GFP mice (Jung et al., 2000) to C57BL/6J mice (The Jackson Laboratory).”
MethodCauses and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · cited 1×
“In addition, neurosteroids including allopregnanolone, DHEA, and (5)PS have been found to modulate allosterically multiple neurotransmitter receptors, such as GABAA, NMDA, and AMPA receptors (Rupprecht and Holsboer, 1999; Belelli and Lambert, 2005; Mameli et al., 2005).”
BackgroundMicroglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047 · cited 1×
“Activation patterns that are excessive in magnitude or prolonged in duration are detrimental to tissue homeostasis and are thought to contribute to chronic neuroinflammatory states in neurodegenerative disease (Lull and Block, 2010).”
BackgroundRupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · cited 3×
“TTN, a DBI-derived peptide, negatively regulates microglial activation via TSPO In addition to its use as a biomarker, TSPO has been explored as a therapeutic target for neuroinflammatory and neurodegenerative diseases (Rupprecht et al., 2010).”
BackgroundGupta, N., Brown, K. E., & Milam, A. H. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00332-9 · Cited by 582
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496
Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 3×
“In comparison, TSPO upregulation in the injured brain was observed in both microglia and astrocytes to varying extents, depending on the nature of the injury and the final severity of associated neurodegeneration (Maeda et al., 2007; Ji et al., 2008; Cosenza-Nashat et al., 2009).”
BackgroundMüller Glial Cells in Retinal Disease
Bringmann, A., & Wiedemann, P. (2012) · Ophthalmologica · doi:10.1159/000328979 · Cited by 436
Rone, M. B., Fan, J., & Papadopoulos, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.001 · Cited by 399
Factors regulating microglia activation
Kierdorf, K., & Prinz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00044 · Cited by 360
Lacapère, J.-J., & Papadopoulos, V. (2003) · Steroids · doi:10.1016/s0039-128x(03)00101-6 · Cited by 342 · cited 1×
“Scale bar indicates 50 m. binding site (Cinone et al., 2000; Lacapère and Papadopoulos, 2003).”
BackgroundFontainhas, A. M., Wang, M., Liang, K. J., Chen, S., Mettu, P., Damani, M., Fariss, R. N., Li, W., & Wong, W. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015973 · Cited by 334 · cited 3×
“…DBI signaling under normal conditions can influence GABAA receptor-mediated visual processing (Bar- mack et al., 2004); how these GABAergic effects feedback onto microglia to influence their function in retinal inflammation is a current topic of study in our laboratory (Fontainhas et al., 2011).”
BackgroundInfluentialSelf-citationParallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
Age related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230 · cited 1×
“Neurodegenerative diseases of the retina, including age-related macular degeneration, diabetic retinopathy, and glaucoma, involve chronic and dysregulated neuroinflammation (Buschini et al., 2011; Vohra et al., 2013).”
BackgroundWang, M., Ma, W., Zhao, L., Fariss, R. N., & Wong, W. T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-173 · Cited by 228
Self-citationThe Role of Inflammation in the Pathogenesis of Glaucoma
Vohra, R., Tsai, J. C., & Kolko, M. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.010 · Cited by 214 · cited 1×
“Neurodegenerative diseases of the retina, including age-related macular degeneration, diabetic retinopathy, and glaucoma, involve chronic and dysregulated neuroinflammation (Buschini et al., 2011; Vohra et al., 2013).”
BackgroundEmbryonic and postnatal development of microglial cells in the mouse retina
Santos, A. M., Calvente, R., Tassi, M., Carrasco, M., Martín‐Oliva, D., Marín‐Teva, J. L., Navascués, J., & Cuadros, M. A. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21538 · Cited by 213 · cited 1×
“In our study, we discovered that TSPO expression in the retina demonstrates developmental regulation; at P0, TSPO was expressed in amoeboid, deramified microglia extravasating into the neural retina (Santos et al., 2008), but was subsequently turned off as microglia acquired a mature ramified morphology in adulthood.”
BackgroundMicroglia in the healthy and degenerating retina: Insights from novel mouse models
Karlstetter, M., Ebert, S., & Langmann, T. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.010 · Cited by 197 · cited 3×
“Discussion Retinal expression of TSPO during development and injury Inflammatory and neurodegenerative diseases of the retina share common features with those afflicting the brain (OhnoMatsui, 2011; Sivak, 2013), including chronic neuroinflammation and microglial activation (Gupta et al., 2003; Karlstetter et al., 201…”
BackgroundJi, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169
Positron Emission Tomography Imaging of Neuroinflammation
Cagnin, A., Kassiou, M., Meikle, S. R., & Banati, R. B. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.04.006 · Cited by 137
Imaging of microglia in patients with neurodegenerative disorders
Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111
Li, H., & Papadopoulos, V. (1998) · Endocrinology · doi:10.1210/en.139.12.4991 · Cited by 94
Choi, H. B., Khoo, C., Ryu, J. K., Van Breemen, E., Kim, S. U., & McLarnon, J. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01122.x · Cited by 82 · cited 2×
“Synthetic ligands to TSPO (PK11195, Ro5– 4864, and etifoxine) have been shown to decrease microglia/macrophage activation in vitro (Choi et al., 2002; Choi et al., 2011) and in animal models of disease, including excitotoxic injury (Ryu et al.”
BackgroundMidzak, A., Akula, N., Lecanu, L., & Papadopoulos, V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203216 · Cited by 69
Neuroprotective effect of Ro5-4864 following brain injury
Soustiel, J. F., Zaaroor, M., Vlodavsky, E., Veenman, L., Weizman, A., & Gavish, M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.008 · Cited by 44 · cited 2×
“We found that PK11195 differed from Ro5-44864 (and TTN) in being not as effective in decreasing TNF expression in cultured microglia, a difference analogous to those previously documented in vivo (Veiga et al., 2005; Soustiel et al., 2008) and which may be attributable to differences in binding sites and also the part…”
Result
Cited by
Tay, T. L., Savage, J. C., Hui, C. W., Bisht, K., & Tremblay, M. (2017) · The Journal of Physiology · doi:10.1113/jp272134 · Cited by 562
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
Self-citationEvidence for brain glial activation in chronic pain patients
Loggia, M. L., Chonde, D. B., Akeju, O., Arabasz, G., Catana, C., Edwards, R. R., Hill, E., Hsu, S., Izquierdo-Garcia, D., Ji, R.-R., et al. (2015) · Brain · doi:10.1093/brain/awu377 · Cited by 503
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Metadata
- Authors
- Wang, M., Wang, X., Zhao, L., Ma, W., Rodriguez, I. R., Fariss, R. N., & Wong, W. T.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2014-03-05
- Volume
- 34
- Issue
- 10
- Pages
- 3793-3806
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2012812017
- Cited by
- 203
- References
- 27
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.